NKT Therapeutics Raises $8 Million
NKT Therapeutics Inc., a Newton, Mass.-based developer of therapeutics based on immune cells called natural killer T (NKT) cells, has raised $8 million in Series A funding co-led by SV Life Sciences and MedImmune Ventures.
16 March 2009•3 mins read
